ENFORCED TUMOR SPECIFIC MHC-I HETEROGENEITY IN TRIPLE NEGATIVE BREAST CANCER DRIVES IMMUNOTHERAPY RESISTANCE

被引：2
|
作者：
Taylor, Brandie [1 ]
Balko, Justin [2 ]
Sanders, Melinda [2 ]
Gonzalez-Ericsson, Paula [2 ]
Sanchez, Violeta [2 ]
机构：
[1] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.318
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
318
引用
收藏
页码：A342 / A342
页数：1
相关论文
共 50 条
  • [21] Immunotherapy in triple-negative breast cancer
    Katz, Heather
    Alsharedi, Mohamed
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [22] Immunotherapy for Triple-Negative Breast Cancer
    Cao, Yifeng
    Chen, Chuyang
    Tao, Yi
    Lin, Weifeng
    Wang, Ping
    PHARMACEUTICS, 2021, 13 (12)
  • [23] Immunotherapy in triple-negative breast cancer
    Heather Katz
    Mohamed Alsharedi
    Medical Oncology, 2018, 35
  • [24] Immunotherapy Treatment for Triple Negative Breast Cancer
    Berger, Elizabeth R.
    Park, Tristen
    Saridakis, Angeleke
    Golshan, Mehra
    Greenup, Rachel A.
    Ahuja, Nita
    PHARMACEUTICALS, 2021, 14 (08)
  • [25] Trials of Immunotherapy in Triple Negative Breast Cancer
    Gumusay, Ozge
    Wabl, Chiara A.
    Rugo, Hope S.
    CURRENT BREAST CANCER REPORTS, 2021, 13 (03) : 171 - 185
  • [26] Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
    Jiang, Lin
    You, Chao
    Xiao, Yi
    Wang, He
    Su, Guan-Hua
    Xia, Bing-Qing
    Zheng, Ren-Cheng
    Zhang, Dan-Dan
    Jiang, Yi-Zhou
    Gu, Ya-Jia
    Shao, Zhi-Ming
    CELL REPORTS MEDICINE, 2022, 3 (07)
  • [27] Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
    Deng, Xiyun
    Zheng, Chanjuan
    Tang, Faqing
    Rosol, Thomas J. J.
    Shao, Zhi-Ming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I–deficient breast cancer cells
    Ming-Zhen Zhao
    Yu Sun
    Xiao-Feng Jiang
    Li Liu
    Li Liu
    Li-Xin Sun
    Immunologic Research, 2019, 67 : 497 - 504
  • [29] IMMUNOESCAPE OF MHC CLASS I-NEGATIVE TUMOR CELLS: IMPLICATIONS FOR CANCER IMMUNOTHERAPY
    Aptsiauri, Natalia
    Garrido, Federico
    TISSUE ANTIGENS, 2014, 84 (01): : 143 - 143
  • [30] Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer
    Thankamony, Archana P.
    Ramkomuth, Sonny
    Ramesh, Shikha T.
    Murali, Reshma
    Chakraborty, Priyanka
    Karthikeyan, Nitheesh
    Varghese, Binitha Anu
    Jaikumar, Vishnu Sunil
    Jolly, Mohit Kumar
    Swarbrick, Alexander
    Nair, Radhika
    FRONTIERS IN ONCOLOGY, 2023, 13
12345